Knee osteoarthritis (OA) is one of the most prevalent musculoskeletal conditions worldwide, affecting hundreds of millions of people and representing a leading cause of pain and functional disability, particularly among older adults. As the global population ages and rates of obesity continue to rise, the burden of knee OA is projected to increase dramatically. Among the many conservative treatment strategies investigated over recent decades, lateral foot wedging — a simple, low-cost biomechanical intervention — has attracted considerable research interest. Despite its intuitive theoretical basis, the clinical evidence surrounding it is nuanced, contested, and ultimately instructive about the complexity of managing a condition as multifactorial as knee OA.
The Biomechanical Rationale
To understand lateral foot wedging, one must first appreciate the biomechanics of the knee in walking. In most people with knee OA, the disease disproportionately affects the medial (inner) compartment of the knee, where cartilage breakdown, subchondral bone changes, and pain are typically concentrated. This medial predominance is not coincidental — during normal gait, the knee experiences a varus (bow-legged) moment that shifts the body’s load toward the inner compartment. This force, quantified as the knee adduction moment (KAM), is a well-established predictor of medial compartment loading and has been associated with OA severity and progression.
Lateral foot wedging — the insertion of a wedge-shaped insole that is thicker on the outer (lateral) edge of the shoe — aims to subtly tilt the foot into eversion. This shifts the ground reaction force vector laterally relative to the knee joint, theoretically reducing the KAM and thereby offloading the medial compartment. The rationale is elegant in its simplicity: if you can redistribute load away from damaged cartilage, you may reduce pain and slow structural deterioration.
Early Promise and Clinical Trials
Initial observational and biomechanical studies lent credibility to this hypothesis. Gait laboratory analyses demonstrated that lateral wedge insoles could reduce the KAM in individuals with medial compartment OA, and early uncontrolled studies reported improvements in pain and functional ability. These findings generated genuine enthusiasm, positioning lateral wedge insoles as an accessible, non-pharmacological option that patients could use without significant side effects or cost.
Several randomised controlled trials (RCTs) followed, with mixed results. Some studies found modest but statistically significant reductions in pain and improvements in physical function with lateral wedge insoles compared to flat insoles or no insoles. A frequently cited advantage was patient adherence — insoles are passive, require no active participation, and can be worn throughout daily life.
However, a number of well-designed trials failed to demonstrate meaningful benefit over control conditions. A landmark trial published in the Journal of the American Medical Association in 2009, which compared lateral wedge insoles to neutral insoles in a large cohort, found no significant difference in pain, function, or walking speed after 12 months. These null results prompted a re-evaluation of the intervention’s true clinical utility.
Systematic Reviews and the Current Consensus
Subsequent systematic reviews and meta-analyses have synthesised this body of evidence with varying conclusions, reflecting the heterogeneity of trial designs, patient populations, insole specifications, and outcome measures. The broad consensus, reflected in guidelines from bodies such as the Osteoarthritis Research Society International (OARSI) and the American College of Rheumatology, is cautious. Lateral wedge insoles are generally not strongly recommended as a standalone intervention, though they are acknowledged as low-risk and potentially useful in carefully selected patients.
One key issue is that biomechanical efficacy does not always translate into clinical benefit. Even when a lateral wedge demonstrably reduces the KAM in the laboratory, this does not guarantee a reduction in pain or structural preservation over time. Knee OA pain is mediated by a complex interplay of peripheral nociception, central sensitisation, synovial inflammation, and psychosocial factors — none of which are directly addressed by shifting foot mechanics alone.
Individual Variability and Subgroup Considerations
A recurring theme in the literature is the importance of patient selection. It is plausible that lateral wedge insoles benefit certain individuals — particularly those with pronounced varus alignment and moderate medial compartment involvement — more than others. Research into biomechanical responders (those who show measurable KAM reductions with wedging) versus non-responders has highlighted that the mechanical effects of insoles vary considerably based on foot posture, gait pattern, and individual anatomy.
There is also emerging interest in combining lateral wedge insoles with other biomechanical interventions, such as knee bracing or footwear modifications, to achieve more meaningful load redistribution. Additionally, studies have examined whether the degree of wedge angle matters, with most clinical trials using wedges between 5° and 10°, though optimal parameters remain uncertain.
Safety and Practicality
One consistent finding across the literature is the favourable safety profile of lateral wedge insoles. Adverse effects are rare and typically minor, including transient discomfort at the ankle or lateral foot and, in some cases, increased lateral knee or hip loading — a potential concern that warrants monitoring in individuals with lateral compartment pathology or hip OA. Compared to pharmacological treatments, which carry gastrointestinal, cardiovascular, and renal risks, or surgical options with their inherent complications, insoles present negligible risk.
From a healthcare economics perspective, lateral wedge insoles are inexpensive and can be prescribed by physiotherapists, podiatrists, or orthopaedic specialists without extensive follow-up. Their simplicity makes them attractive in resource-limited settings, and patient acceptance tends to be high when expectations are appropriately managed.
Lateral foot wedging for knee osteoarthritis exemplifies both the promise and the limitations of biomechanical approaches to musculoskeletal disease. The underlying rationale is sound, and laboratory evidence confirms that wedging can alter knee loading in a mechanically meaningful way. Yet clinical trials have repeatedly demonstrated that this mechanical effect does not reliably translate into superior pain relief or functional improvement at the population level. The intervention works best when viewed not as a standalone cure but as one component of a broader, individualised management strategy — one that might also include exercise therapy, weight management, education, and appropriate analgesia. For clinicians, the message is one of selective application: lateral wedge insoles may offer real benefit to the right patient, but blanket prescription is unlikely to yield consistent results. Continued research into patient stratification and combined approaches will be essential to unlocking whatever clinical potential this simple, accessible intervention genuinely holds.